"10.1371_journal.pone.0070101","plos one","2013-07-25T00:00:00Z","Kjetil H LÃ¸land; Ã˜yvind Bleie; Elin Strand; Per M Ueland; Jan E Nordrehaug; Hector M Garcia-Garcia; Patrick W Serruys; Ottar NygÃ¥rd","Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway; Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway; Cardialysis, Rotterdam, The Netherlands; Interventional Cardiology Department, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands","Conceived and designed the experiments: Ã˜B PMU JEN HGG PWS ON. Performed the experiments: Ã˜B ON JEN. Analyzed the data: KHL Ã˜B HGG ES. Contributed reagents/materials/analysis tools: KHL Ã˜B ES PMU HGG PWS. Wrote the manuscript: KHL Ã˜B. Substantial revision and contribution to the written manuscript: ON JEN PMU HGG PWS.","Alpharma Inc provided the study capsules, generated the randomization sequence, and concealed the randomization code free of charge and rendered a limited grant to finance the initial phase of the trial. However, Alpharma Inc had no role in the design or implementation of the trial, had no access to study data, and did not participate in data analysis or interpretation or in the preparation, review, or approval of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Kjetil H LÃ¸land","KHLÃ",8,TRUE,6,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
